Literature DB >> 6665516

Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics.

P V Luoma, E A Sotaniemi, A J Arranto.   

Abstract

The association of serum LDL and HDL cholesterol with hepatic microsomal enzyme induction, assessed by plasma antipyrine kinetics was investigated in 30 epileptics. Patients on enzyme-inducing anticonvulsants had reduced LDL/HDL cholesterol ratios and elevated HDL cholesterol concentrations and HDL/total cholesterol ratios, indicating a cholesterol transfer from LDL to HDL. Strong hepatic microsomal enzyme induction was associated with reduced LDL cholesterol. The LDL/HDL cholesterol ratio was negatively proportional and the HDL/total cholesterol ratio positively proportional to the antipyrine clearance rate. Epileptics, particularly those with a high antipyrine clearance, had a cholesterol distribution pattern characteristic of a low probability of developing coronary atherosclerosis. The results support the view that hepatic microsomal enzyme induction favourably alters the cholesterol distribution in the body.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6665516

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  9 in total

1.  High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects.

Authors:  P V Luoma; A Rautio; J Stengård; E A Sotaniemi; J Marniemi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy.

Authors:  R Tempelhoff; P A Modica; E L Spitznagel
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

3.  Serum selenium, glutathione peroxidase, lipids, and human liver microsomal enzyme activity : A double-blind controlled trial of selenium supplementation.

Authors:  P V Luoma; H Korpela; E A Sotaniemi; J Kumpulainen
Journal:  Biol Trace Elem Res       Date:  1985-09       Impact factor: 3.738

4.  Variations in lipoproteins during aminoglutethimide therapy.

Authors:  J Bonneterre; N Ghalim; M Nguyen; P Puchois; A Demaille; C Demarquilly; J C Fruchart
Journal:  Breast Cancer Res Treat       Date:  1987-11       Impact factor: 4.872

Review 5.  Cytochrome P450 and gene activation--from pharmacology to cholesterol elimination and regression of atherosclerosis.

Authors:  Pauli V Luoma
Journal:  Eur J Clin Pharmacol       Date:  2008-07-17       Impact factor: 2.953

Review 6.  Changes of serum lipid patterns during long-term anticonvulsive treatment.

Authors:  J Zeitlhofer; A Doppelbauer; G Tribl; T Leitha; L Deecke
Journal:  Clin Investig       Date:  1993-07

Review 7.  Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia.

Authors:  P V Luoma
Journal:  Curr Mol Med       Date:  2011-07       Impact factor: 2.222

Review 8.  Elimination of endoplasmic reticulum stress and cardiovascular, type 2 diabetic, and other metabolic diseases.

Authors:  Pauli V Luoma
Journal:  Ann Med       Date:  2012-08-28       Impact factor: 4.709

9.  Discontinuation of carbamazepine due to concerns of long-term consequences of enzyme induction.

Authors:  Jussi Mäkinen; Sirpa Rainesalo; Jani Raitanen; Jukka Saarinen; Satu Sandell; Jukka Peltola
Journal:  Epilepsia Open       Date:  2018-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.